hotspot -WSS

hotspot

author：explore 2025-10-01 10:57:01 - browse：5224

Liver illustration — Hyacinth Empinado/STAT

SAN DIEGO — The American Diabetes Association said Sunday that all adults with type 2 diabetes or prediabetes should be screened for nonalcoholic fatty liver disease, an increasingly prevalent condition that can lead to serious liver damage.

There are no approved medications for the disease, but among available diabetes drugs, the ADA singled out GLP-1 treatments as an option doctors could consider, according to recommendations published during the annual ADA conference.

GLP-1 treatments, such as Ozempic and Mounjaro, are a class of drugs that have grown widely popular for their efficacy not only in lowering blood sugar, but also cutting weight. Drugmakers have started to study them in liver disease, and while some trials have shown they may offer some benefits, they haven’t yet been shown to improve harmful liver scarring.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Life science postdocs should get big pay hike, NIH panel says

hotspot

WSS

Hospital chaplains balance Covid safety with patients’ spiritual needs

What the Wegovy shortage looks like for doctors — and for patients

Medicare to cover more brain scans related to Alzheimer’s drugs

In shift, Texas to cover initial consult for Afghan baby's gene therapy

There’s no way to know how good AI health technologies are

Nonprofit, backed by Microsoft, to certify AI tools in health care

Wikipedia

hotspot

hotspot

In Memoriam: Notable people who died in 2023

Readout LOUD podcast: Merger Mondays, Ozempic panic

Malaria cases in Florida and Texas: Here’s what you need to know

European regulators consider appeal over Amylyx ALS drug

How to save PrEP access — and even expand it

STAT Readout: Today's biotech news includes Sana and Amylyx

Continuity nursing helped my family in our darkest PICU moments

Allen Institute goes after foundational questions, CEO Costa says

Virginia high school admissions case could be legal follow

Massive project maps cells in human brain in unprecedented detail

explore

At JPM 2024, hospital systems pitch financial strength to investors

European regulators consider appeal over Amylyx ALS drug

FDA early review: GLP

Peter Marks talks Operation Warp Speed for Rare Diseases

Readout LOUD podcast: Merger Mondays, Ozempic panic

Stories you might have missed in 2023: health, science, medicine

entertainment

explore

hotspot

focus